Seres Therapeutics (MCRB) Times Interest Earned (2020 - 2024)
Seres Therapeutics (MCRB) has disclosed Times Interest Earned for 5 consecutive years, with -$55.72 as the latest value for Q1 2024.
- Quarterly Times Interest Earned fell 53.83% to -$55.72 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was -$196.3 through Dec 2024, down 881.94% year-over-year, with the annual reading at -$79.05 for FY2023, 164.51% down from the prior year.
- Times Interest Earned hit -$55.72 in Q1 2024 for Seres Therapeutics, down from $15.54 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $91.94 in Q3 2021 to a low of -$66.98 in Q4 2021.
- Historically, Times Interest Earned has averaged -$28.48 across 5 years, with a median of -$36.23 in 2023.
- Biggest YoY gain for Times Interest Earned was 323.77% in 2021; the steepest drop was 184.05% in 2021.
- Year by year, Times Interest Earned stood at -$23.58 in 2020, then crashed by 184.05% to -$66.98 in 2021, then soared by 98.63% to -$0.92 in 2022, then soared by 1787.7% to $15.54 in 2023, then tumbled by 458.6% to -$55.72 in 2024.
- Business Quant data shows Times Interest Earned for MCRB at -$55.72 in Q1 2024, $15.54 in Q2 2023, and -$36.23 in Q1 2023.